Table 4 OS analysis for patients with colon cancer
Characteristics | Â | RMSTb (95%CI) | HRc (95%CI) | P valuea | Interaction p | |
|---|---|---|---|---|---|---|
Non-chemotherapy | Chemotherapy | |||||
Total | – | 55.2 (52.8–57.0) | 56.9 (55.2–58.0) | 0.612 (0.321–1.168) | 0.132 | – |
Sex | Male | 55.0 (51.1–57.2) | 56.7 (54.3–58.2) | 0.636 (0.269–1.502) | 0.298 | 0.887 |
Female | 55.4 (51.1–57.7) | 57.2 (54.5–58.6) | 0.599 (0.225–1.599) | 0.301 |  | |
Age (years) | ≤55 | 52.0 (40.0–57.2) | 57.5 (54.0–58.9) | 0.262 (0.062–1.107) | 0.050 | 0.179 |
56–60 | 56.0 (38.7–59.5) | 57.0 (52.2–58.9) | 0.849 (0.095–7.617) | 0.884 |  | |
61–65 | 55.4 (43.1–58.8) | 55.7 (51.1–57.8) | 0.882 (0.176–4.421) | 0.879 |  | |
66–70 | 52.9 (45.9–56.5) | – | 0.015 (0.001–10.71) | 0.014 |  | |
> 70 | 56.8 (53.0–58.5) | 54.9 (47.8–58.0) | 1.569 (0.442–5.569) | 0.482 |  | |
Size (cm) | ≤5.0 | 55.6 (51.7–57.6) | 56.3 (53.7–57.9) | 0.849 (0.341–2.114) | 0.724 | 0.254 |
> 5.0 | 53.7 (50.5–55.8) | 56.3 (54.5–57.5) | 0.452 (0.178–1.146) | 0.086 |  | |
Differentiation | Well-moderate | 53.9 (52.0–55.4) | 56.3 (55.2–57.2) | 0.621 (0.310–1.246) | 0.175 | 0.990 |
Poor | 52.0 (43.2–56.6) | 54.7 (46.8–57.8) | 0.594 (0.099–3.561) | 0.564 |  | |
T category | 3 | 56.4 (53.7–58.0) | 57.6 (55.5–58.6) | 0.581 (0.116–2.907) | 0.504 | 0.746 |
4 | 51.8 (49.2–54.0) | 55.6 (54.2–56.8) | 0.575 (0.284–1.165) | 0.119 |  | |
CEAd (ng/mL) | < 5 | 54.6 (51.9–56.4) | 56.7 (55.3–57.8) | 0.606 (0.219–1.675) | 0.329 | 0.522 |
≥5 | 53.5 (50.1–55.7) | 55.1 (52.8–56.8) | 0.793 (0.305–2.061) | 0.633 |  | |
Examined lymph nodes | < 12 | 52.0 (47.5–54.9) | 53.6 (50.2–55.6) | 0.626 (0.216–1.816) | 0.383 | 0.949 |
≥12 | 54.5 (52.3–56.0) | 57.1 (55.9–57.9) | 0.670 (0.293–1.534) | 0.340 |  | |
PLRe | ≤130 | 56.0 (53.6–57.6) | 56.0 (54.3–57.2) | 1.093 (0.328–3.647) | 0.885 | 0.276 |
> 130 | 51.3 (47.8–53.7) | 56.5 (54.8–57.7) | 0.464 (0.211–1.024) | 0.051 |  | |